Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. [electronic resource]
- Journal of the American Heart Association May 2017
Australia Brain Ischemia--diagnosis Canada Combined Modality Therapy Cost Savings Cost-Benefit Analysis Disability Evaluation Endovascular Procedures--adverse effects Europe Fibrinolytic Agents--administration & dosage Health Care Costs Health Resources--economics Humans Infusions, Intravenous Length of Stay--economics Process Assessment, Health Care--economics Prospective Studies Quality-Adjusted Life Years Stroke--diagnosis Thrombolytic Therapy--adverse effects Time Factors Tissue Plasminogen Activator--administration & dosage Treatment Outcome United States